
GeoVax Labs, Inc.
GOVXHealthcare|Biotechnology|US
$0.16
-0.00 (-0.06%)
DCF Value
$0.17
Tangible Book / Share
$0.39
Cash / Share
$0.69
Ownership Breakdown
100.0%
Float
10.1M
Shares Outstanding
10.1M
Float Shares
Major Holders (12)
Combined: 40.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Steven Boyd | HC, IN | 4.99% | 387,038 | Aug 14, 2026 | 13D/G |
| Armistice Capital, LLC | IA, OO | 4.99% | 387,038 | Aug 14, 2026 | 13D/G |
| Daniel B. Asher | HC, IN | 4.99% | 273,657 | Aug 13, 2026 | 13D/G |
| Intracoastal Capital LLC | Other | 4.99% | 273,657 | Aug 13, 2026 | 13D/G |
| Mitchell P. Kopin | HC, IN | 4.99% | 273,657 | Aug 13, 2026 | 13D/G |
| Jane Street Group, LLC | Holding company | 4.30% | 315,275 | Aug 10, 2026 | 13D/G |
| Jane Street Capital, LLC | Broker-dealer | 2.20% | 161,270 | Aug 10, 2026 | 13D/G |
| Jane Street Global Trading, LLC | Other | 2.10% | 154,005 | Aug 10, 2026 | 13D/G |
| L1 Capital Global Opportunities Master Fund, Ltd. | Non-US institution | 1.79% | 547,715 | Feb 17, 2026 | 13D/G |
| Waqas Khatri | Individual | 1.59% | 118,715 | Aug 13, 2026 | 13D/G |
| Ayrton Capital LLC | IA, CO | 1.59% | 118,715 | Aug 13, 2026 | 13D/G |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | Corporation | 1.59% | 118,715 | Aug 13, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 713,507 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Uppal Manpreet | director: | Oct 25, 2026 | OTHER | 0 | — | — | Form 4 |
| Brown Steven Collier | director: | Oct 25, 2026 | OTHER | 0 | — | — | Form 4 |
| SPENCER JOHN N JR | director | Jun 17, 2026 | AWARD | 6,000 | $1.18 | $7.1K | Form 4 |
| Morgan Jayne | director | Jun 17, 2026 | AWARD | 6,000 | $1.18 | $7.1K | Form 4 |
| MCNALLY ROBERT T | director | Jun 17, 2026 | AWARD | 6,000 | $1.18 | $7.1K | Form 4 |
| Lemerond Nicole | director | Jun 17, 2026 | AWARD | 6,000 | $1.18 | $7.1K | Form 4 |
| Kollintzas Dean G | director | Jun 17, 2026 | AWARD | 6,000 | $1.18 | $7.1K | Form 4 |
| CHASE RANDAL D | director | Jun 17, 2026 | AWARD | 6,000 | $1.18 | $7.1K | Form 4 |
| Sharkey John W. | VP, Business Development | Jun 17, 2026 | AWARD | 17,600 | $1.18 | $20.8K | Form 4 |
| Reynolds Mark | CFO | Jun 17, 2026 | AWARD | 17,600 | $1.18 | $20.8K | Form 4 |
| NEWMAN MARK J | Chief Scientific Officer | Jun 17, 2026 | AWARD | 17,600 | $1.18 | $20.8K | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | Jun 17, 2026 | AWARD | 17,600 | $1.18 | $20.8K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Jun 17, 2026 | AWARD | 29,300 | $1.18 | $34.6K | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | Aug 7, 2025 | BUY | 1,107 | $0.67 | $741.69 | Form 4 |
| Lemerond Nicole | director | Jun 5, 2025 | AWARD | 10,000 | $2.48 | $24.8K | Form 4 |
| CHASE RANDAL D | director | Jun 5, 2025 | AWARD | 10,000 | $2.48 | $24.8K | Form 4 |
| Kollintzas Dean G | director | Jun 5, 2025 | AWARD | 10,000 | $2.48 | $24.8K | Form 4 |
| MCNALLY ROBERT T | director | Jun 5, 2025 | AWARD | 10,000 | $2.48 | $24.8K | Form 4 |
| Morgan Jayne | director | Jun 5, 2025 | AWARD | 10,000 | $2.48 | $24.8K | Form 4 |
| SPENCER JOHN N JR | director | Jun 5, 2025 | AWARD | 10,000 | $2.48 | $24.8K | Form 4 |
| NEWMAN MARK J | Chief Scientific Officer | Jun 5, 2025 | AWARD | 70,000 | $2.48 | $173.6K | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | Jun 5, 2025 | AWARD | 70,000 | $2.48 | $173.6K | Form 4 |
| Sharkey John W. | VP, Business Development | Jun 5, 2025 | AWARD | 70,000 | $2.48 | $173.6K | Form 4 |
| Reynolds Mark | CFO | Jun 5, 2025 | AWARD | 70,000 | $2.48 | $173.6K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Jun 5, 2025 | AWARD | 185,500 | $2.48 | $460.0K | Form 4 |
| SPENCER JOHN N JR | director | Apr 10, 2025 | BUY | 10,000 | $0.98 | $9.8K | Form 4 |
| Sharkey John W. | VP, Business Development | Apr 10, 2025 | BUY | 6,000 | $0.99 | $5.9K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Apr 1, 2025 | BUY | 10,000 | $1.08 | $10.8K | Form 4 |
| Reynolds Mark | CFO | Mar 31, 2025 | BUY | 6,800 | $1.08 | $7.3K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Aug 12, 2024 | AWARD | 35,000 | $2.17 | $76.0K | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | Aug 12, 2024 | AWARD | 15,700 | $2.17 | $34.1K | Form 4 |
| NEWMAN MARK J | Chief Scientific Officer | Aug 12, 2024 | AWARD | 15,700 | $2.17 | $34.1K | Form 4 |
| Reynolds Mark | CFO | Aug 12, 2024 | AWARD | 15,700 | $2.17 | $34.1K | Form 4 |
| Sharkey John W. | VP, Business Development | Aug 12, 2024 | AWARD | 15,700 | $2.17 | $34.1K | Form 4 |
| CHASE RANDAL D | director | Aug 12, 2024 | AWARD | 8,050 | $2.17 | $17.5K | Form 4 |
| Kollintzas Dean G | director | Aug 12, 2024 | AWARD | 8,050 | $2.17 | $17.5K | Form 4 |
| Lemerond Nicole | director | Aug 12, 2024 | AWARD | 8,050 | $2.17 | $17.5K | Form 4 |
| MCNALLY ROBERT T | director | Aug 12, 2024 | AWARD | 8,050 | $2.17 | $17.5K | Form 4 |
| Morgan Jayne | director | Aug 12, 2024 | AWARD | 8,050 | $2.17 | $17.5K | Form 4 |
| SPENCER JOHN N JR | director | Aug 12, 2024 | AWARD | 8,050 | $2.17 | $17.5K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Aug 9, 2024 | BUY | 8,000 | $1.95 | $15.6K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Feb 22, 2024 | BUY | 8,209 | $2.27 | $18.7K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Feb 21, 2024 | BUY | 520 | $2.15 | $1.1K | Form 4 |
| Reynolds Mark | CFO | Feb 7, 2024 | BUY | 2,000 | $2.77 | $5.5K | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | Dec 22, 2023 | BUY | 6,944 | $0.36 | $2.5K | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | Sep 25, 2023 | BUY | 9,653 | $0.52 | $5.0K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Aug 25, 2023 | BUY | 35,087 | $0.57 | $20.0K | Form 4 |
| Reynolds Mark | CFO | Aug 18, 2023 | BUY | 10,000 | $0.52 | $5.2K | Form 4 |
| SPENCER JOHN N JR | director | Aug 1, 2023 | AWARD | 50,000 | $0.76 | $37.8K | Form 4 |
| Morgan Jayne | director | Aug 1, 2023 | AWARD | 50,000 | $0.76 | $37.8K | Form 4 |
| MCNALLY ROBERT T | director | Aug 1, 2023 | AWARD | 50,000 | $0.76 | $37.8K | Form 4 |
| Lemerond Nicole | director | Aug 1, 2023 | AWARD | 50,000 | $0.76 | $37.8K | Form 4 |
| Kollintzas Dean G | director | Aug 1, 2023 | AWARD | 50,000 | $0.76 | $37.8K | Form 4 |
| CHASE RANDAL D | director | Aug 1, 2023 | AWARD | 50,000 | $0.76 | $37.8K | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | Aug 1, 2023 | AWARD | 15,000 | $0.76 | $11.3K | Form 4 |
| Sharkey John W. | VP, Business Development | Aug 1, 2023 | AWARD | 100,000 | $0.76 | $75.5K | Form 4 |
| NEWMAN MARK J | Chief Scientific Officer | Aug 1, 2023 | AWARD | 100,000 | $0.76 | $75.5K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Aug 1, 2023 | AWARD | 250,000 | $0.76 | $188.8K | Form 4 |
| Reynolds Mark | CFO | Aug 1, 2023 | AWARD | 100,000 | $0.76 | $75.5K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Apr 24, 2023 | BUY | 32,000 | $0.64 | $20.4K | Form 4 |
| Reynolds Mark | CFO | Apr 20, 2023 | BUY | 8,000 | $0.63 | $5.0K | Form 4 |
| Morgan Jayne | director: | Dec 7, 2022 | OTHER | 0 | — | — | Form 4 |
| Morgan Jayne | Dec 7, 2022 | OTHER | — | — | — | Form 4 | |
| CHASE RANDAL D | director | Sep 21, 2022 | BUY | 10,000 | $1.10 | $11.0K | Form 4 |
| Lemerond Nicole | director: | Aug 31, 2022 | OTHER | 0 | — | — | Form 4 |
| Sharkey John W. | VP, Business Development | Jul 1, 2022 | BUY | 1,000 | $0.82 | $820.00 | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | Jun 27, 2022 | BUY | 4,464 | $1.12 | $5.0K | Form 4 |
| CHASE RANDAL D | director: | Jun 21, 2022 | BUY | 10,000 | $1.21 | $12.1K | Form 4 |
| Sharkey John W. | VP, Business Development | Jun 13, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Sharkey John W. | VP, Business Development | Jun 13, 2022 | DISPOSED | 10,000 | $3.82 | $38.2K | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | May 5, 2022 | BUY | 9,722 | $0.72 | $7.0K | Form 4 |
| McKee Kelly T. Jr. | Chief Medical Officer | May 4, 2022 | BUY | 4,999 | $0.71 | $3.5K | Form 4 |
| McKee Kelly T. Jr. | officer | Jan 6, 2022 | OTHER | 0 | — | — | Form 4 |
| SPENCER JOHN N JR | director | Dec 7, 2021 | AWARD | 25,000 | $3.82 | $95.5K | Form 4 |
| MCNALLY ROBERT T | director | Dec 7, 2021 | AWARD | 25,000 | $3.82 | $95.5K | Form 4 |
| Kollintzas Dean G | director | Dec 7, 2021 | AWARD | 25,000 | $3.82 | $95.5K | Form 4 |
| CHASE RANDAL D | director | Dec 7, 2021 | AWARD | 25,000 | $3.82 | $95.5K | Form 4 |
| NEWMAN MARK J | Chief Scientific Officer | Dec 7, 2021 | AWARD | 25,700 | $3.82 | $98.2K | Form 4 |
| Reynolds Mark | CFO | Dec 7, 2021 | AWARD | 48,200 | $3.82 | $184.1K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Dec 7, 2021 | AWARD | 103,000 | $3.82 | $393.5K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Aug 11, 2021 | AWARD | 273,000 | $2.79 | $761.7K | Form 4 |
| Reynolds Mark | CFO | Aug 11, 2021 | AWARD | 128,000 | $2.79 | $357.1K | Form 4 |
| NEWMAN MARK J | Chief Scientific Officer | Aug 11, 2021 | AWARD | 35,000 | $2.79 | $97.7K | Form 4 |
| Kollintzas Dean G | director | Aug 11, 2021 | AWARD | 25,000 | $2.79 | $69.8K | Form 4 |
| MCNALLY ROBERT T | director | Aug 11, 2021 | AWARD | 25,000 | $2.79 | $69.8K | Form 4 |
| CHASE RANDAL D | director | Aug 11, 2021 | AWARD | 25,000 | $2.79 | $69.8K | Form 4 |
| SPENCER JOHN N JR | director | Aug 11, 2021 | AWARD | 25,000 | $2.79 | $69.8K | Form 4 |
| Reynolds Mark | CFO | Sep 29, 2020 | BUY | 60,184 | $5.00 | $300.9K | Form 4 |
| Reynolds Mark | CFO | Sep 29, 2020 | BUY | 60,184 | $5.00 | $300.9K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Sep 29, 2020 | BUY | 81,870 | $5.00 | $409.4K | Form 4 |
| DODD DAVID A | director, officer: President, CEO | Sep 29, 2020 | BUY | 81,870 | $5.00 | $409.4K | Form 4 |
| MCNALLY ROBERT T | director | Sep 29, 2020 | BUY | 53,925 | $5.00 | $269.6K | Form 4 |
| MCNALLY ROBERT T | director | Sep 29, 2020 | BUY | 53,925 | $5.00 | $269.6K | Form 4 |
| SPENCER JOHN N JR | director | Sep 29, 2020 | BUY | 21,024 | $5.00 | $105.1K | Form 4 |
| SPENCER JOHN N JR | director | Sep 29, 2020 | BUY | 21,024 | $5.00 | $105.1K | Form 4 |
| Kollintzas Dean G | director | Sep 29, 2020 | BUY | 11,987 | $5.00 | $59.9K | Form 4 |
| Kollintzas Dean G | director | Sep 29, 2020 | BUY | 11,987 | $5.00 | $59.9K | Form 4 |
| CHASE RANDAL D | director | Sep 29, 2020 | BUY | 16,613 | $5.00 | $83.1K | Form 4 |
| CHASE RANDAL D | director | Sep 29, 2020 | BUY | 16,613 | $5.00 | $83.1K | Form 4 |
| NEWMAN MARK J | officer | Aug 25, 2020 | OTHER | 0 | — | — | Form 4 |